|
HS Code |
568102 |
| Cas Number | 94421-68-8 |
| Molecular Formula | C22H37NO2 |
| Molecular Weight | 347.53 g/mol |
| Appearance | Oil |
| Synonyms | Anandamide; AEA |
| Purity | Typically ≥98% |
| Storage Temperature | -20°C |
| Solubility | Soluble in ethanol, DMSO, and chloroform |
| Iupac Name | N-(2-hydroxyethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide |
| Chemical Class | Endocannabinoid |
| Source | Synthetic or extracted from animal tissues |
As an accredited Ethanolamine Arachidonic Acid (AEA) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass vial containing 10 mg Ethanolamine Arachidonic Acid (AEA) powder, securely sealed with tamper-evident cap and labeled. |
| Shipping | Ethanolamine Arachidonic Acid (AEA) is shipped in tightly sealed, amber glass containers to protect from light and moisture. The chemical is transported under controlled, ambient temperatures with clear hazard labeling, and all documentation complies with international regulations for the safe shipment of biochemical substances. Expedited delivery options are available. |
| Storage | Ethanolamine Arachidonic Acid (AEA) should be stored at -20°C or lower, protected from light and moisture to maintain stability. Use tightly sealed containers, preferably under an inert gas like nitrogen or argon to prevent oxidation. Minimize freeze-thaw cycles and exposure to air. Proper storage ensures the compound retains its chemical integrity and biological activity for research applications. |
| Purity 98%: Ethanolamine Arachidonic Acid (AEA) with purity 98% is used in neuropharmacological research, where high purity ensures reproducible receptor binding assays.Molecular Weight 347.53 g/mol: Ethanolamine Arachidonic Acid (AEA) with molecular weight 347.53 g/mol is used in cannabinoid signaling studies, where precise molecular weight enables accurate dosage calculations.Melting Point -1°C: Ethanolamine Arachidonic Acid (AEA) with melting point of -1°C is used in lipid membrane integration experiments, where phase transition at low temperature supports membrane fluidity analysis.Stability Temperature 4°C: Ethanolamine Arachidonic Acid (AEA) stable at 4°C is used in pharmaceutical formulations, where enhanced stability prevents degradation during storage.Particle Size <5 µm: Ethanolamine Arachidonic Acid (AEA) with particle size less than 5 µm is used in nanoemulsion preparations, where small particle size promotes homogeneous dispersion.Viscosity 50 mPa∙s: Ethanolamine Arachidonic Acid (AEA) with viscosity of 50 mPa∙s is used in topical delivery systems, where optimal viscosity assists in controlled release properties.Solubility in Ethanol >10 mg/mL: Ethanolamine Arachidonic Acid (AEA) soluble in ethanol above 10 mg/mL is used in analytical chemistry, where high solubility facilitates sample preparation.pH Stability 6.0–8.0: Ethanolamine Arachidonic Acid (AEA) stable at pH 6.0–8.0 is used in cell culture studies, where pH stability maintains compound integrity in biological environments. |
Competitive Ethanolamine Arachidonic Acid (AEA) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As the team who actually manufactures Ethanolamine Arachidonic Acid, often abbreviated as AEA, we have to pay close attention to every variable in our production. We handle the pure chemistry, manage strict raw material sourcing, and watch each reactor ourselves from batch to batch. Our AEA stands for consistency in both composition and performance. This compound draws significant interest in sectors looking to study or apply lipid signaling, neurological modulation, and membrane biophysics. We don’t just supply it to the marketplace — we create it, troubleshoot challenges, and keep the process as transparent as possible for our partners.
Our Ethanolamine Arachidonic Acid goes through multiple quality checks before leaving our site. We measure its purity by both HPLC and mass spectrometry, ensuring that it consistently meets or exceeds 98% purity. Direct, in-house control over synthesis lets us minimize by-products and contaminants, such as oxidized lipids or residual solvents. A single impurity can throw off sensitive research or derail high-performance formulations, something we have experienced ourselves and work hard to avoid. The chemical model for AEA — essentially a fatty acid amide of arachidonic acid and ethanolamine — means hydrolytic stability and reliable performance in both in-vitro test setups and more challenging applications.
Making AEA is not a simple matter of mixing ingredients and hoping for the best. We use carefully selected arachidonic acid, subject to thorough peroxide value checks. Ethanolamine quality gets equal scrutiny. Small changes in the ratio, humidity, or reaction pH yield visible differences in end-product color, odor, and storage profile. Over years of practice, we’ve learned that slow addition of reactants, constant pH monitoring, and nitrogen atmosphere contribute directly to superior, fresh-smelling, white AEA. Some may overlook these steps to boost yield, but we’ve seen firsthand how lapses here lead to early oxidation, discolored lots, or even loss of function upon storage. Freeze-drying after reaction, immediate packaging in inert conditions, and continuous freezer storage all help keep your material potent and effective.
In research circles and commercial applications, some confusion still exists between AEA and structurally similar lipids or amides. An N-acylethanolamine might sound similar on paper, but only true AEA matches both the signaling capacity and physicochemical properties needed for control experiments, bioassays, and advanced product development. Other products, like palmitoylethanolamide or oleoylethanolamide, share broad family traits but lack the arachidonic acid backbone, and therefore do not interact with key receptors the way AEA does. The difference turns out to be more than academic. One example: enzymatic breakdown patterns diverge, leading to alternate product profiles over time in either cell culture or finished formulations. We've seen more than one client inadvertently select the wrong structure, only to come to us for help troubleshooting after assays fail or pilot runs underperform.
End-users rely on detailed guidance from us — the source — for practical matters. We get phone calls, not about sales but about specific requirements: solubility in various organic buffers, stability under light exposure, or optimal storage between shipments. This compound starts to degrade in high-humidity or elevated temperature environments. AEA’s lipid nature makes it stick to glass, plastics, and even rubber stoppers in analytical containers, a quirk we observe every single day and pass on tips to those preparing working solutions. Our process accounts for these losses through careful packaging and dosing recommendations.
Lab technicians often seek out our advice for choice of solvents. Ethanol, chloroform, and DMSO dissolve the product efficiently, while water does not. We make sure to highlight that sonication or gentle heating — never vigorous shaking — disperses the compound without inducing oxidative breakdown, because we have learned from ruined batches and know the pain of lost time and material.
Having skin in the game makes a difference. We experience the daily realities of margin squeeze in sourcing, equipment downtime, and regulatory shifts. Ethanolamine Arachidonic Acid’s price moves with upstream raw arachidonic acid volatility and shifts in global chemical transportation. As manufacturers, we’re able to buffer some of these swings for our customers by stockpiling, sequencing our process runs, or adjusting to container shortages. These are practical matters that distributors and brokers rarely address, but which make or break reliability for researchers or industrial innovators who count on uninterrupted supply.
Direct manufacturing also gives us flexibility. If a client requires custom pack sizes, or an atypically high-purity lot for an especially sensitive bioassay, we’re able to revalidate our process with a tighter specification. We’ve produced AEA with extra validation steps for clinical development, even going as far as producing documentation packs, traceable chain-of-custody for every gram, and on-demand batch-specific certificates that tie directly to our internal quality logs.
Far from being a generic commodity, AEA shows different faces depending on use. Researchers in neuroscience trust our product for consistent action in receptor binding experiments, EEG studies, and cellular response assays. The material’s high purity enables accurate titration for dose-response curves in both animal and cell culture models. Our partners in the pharmaceutical prototype industry reach out for advice on scaling up solubility tests or introducing AEA into delivery vehicles. We even stay in the loop during downstream processing, troubleshooting precipitation, compatibility, and packaging design by sharing data from our own stability testing.
Formulators using AEA in cosmetic or topical applications face different challenges. Oxidation and odor change can creep in during product development. Because our manufacturing site is built around immediate cold-chain handoff and nitrogen packaging, we’re able to supply fresh, batch-coded material, mitigating early-stage rancidity or loss of bioactivity. Direct relationships with end-users give us the feedback channels needed to tweak process settings when required.
Years of manufacturing have cemented a deep appreciation for regulatory and scientific ethics. As controls have become stricter, we’ve never compromised on full disclosure of known impurities, shelf-life behavior, and stability data. Before official batch release, our lab submits random samples for third-party verification. The resulting transparency is not an afterthought — it keeps our product trusted by credentialed researchers, regulatory inspectors, and procurement auditors alike.
Part of this commitment extends into documenting — not just complying with — green chemistry practices. Solvent recycling, careful energy use, and waste by-product tracking occur at all stages. By taking these steps early, we prevent issues from trickling down the supply chain to either our customers or the environment. This approach has allowed us to open a real conversation about sustainable manufacturing practices in specialty lipids. We’re always interested in feedback from end-users regarding both packaging and handling waste, as both impact the final environmental footprint.
Meeting seemingly contradictory goals — price control, high purity, reliable lead times — takes more than a few tweaks in manufacturing. With market demand shifting, and global logistics challenged, we invest in both process optimization and communication. For example, to tackle occasional supply chain bottlenecks, we build buffer stocks of critical raw materials and maintain a live dialogue with transport companies, keeping updated on cold-chain continuity and customs clearance rules. This proactive approach directly benefits customers facing time-sensitive projects.
We also recognize that users can face shelf-life disappointment if not armed with clear instructions. That drives us to ship every consignment of AEA with updated recommendations and clear labeling directly describing expiry, optimal storage, as well as easy-to-read batch and tracking information. At times, we’ve even set up short video briefings and PDF guides, because we’ve seen that written protocols, while necessary, sometimes fail to translate into day-to-day lab habits. Experienced users appreciate these materials, as do new entrants taking their first steps into lipid research.
Many who purchase AEA see only the final container. The day-to-day, behind-the-scenes discipline of maintaining chemical identity and purity often fades into the background. We insist on communicating the manufacturing journey to our end-users, unpacking every step from raw input checks, reaction chemistry, isolation, drying, to final QC. Because no two batches of raw arachidonic acid ever present exactly the same, our plant operators adjust times, temperatures, and even scavenger addition by hand, overseen by experienced chemists who know the signs of subpar intermediate. This hands-on approach contrasts sharply with remote, automated facilities, where response to process deviations may lag hours or even days.
Users who take the time to visit our facility walk away understanding the difference. They see rows of small batch reactors, tight sample tracking, and a manufacturing team ready to answer detailed questions about fatty acid profile, oxidation markers, or solvent history. They realize the product in their hands carries the signature of chemistry performed at scale, rather than just the label of another supplier.
Supplying AEA is less about shipping a chemical and more about building a partnership with advanced users. We keep open communication channels and act on lessons learned from product failures as much as successes. Our technical team remains available for troubleshooting and quickly implements process changes when recurring concerns surface from different users — for example, tweaking storage procedures in response to rising temperature excursions in summer, or revising our own glassware cleaning routines based on feedback about trace contaminants.
Feedback from the field led us to switch certain packaging types, introduce tamper-evident seals, and provide fresh aliquots of AEA, lowering the oxidative risk faced by customers who may not use bulk containers quickly. We document these changes and offer users the opportunity to contribute suggestions, knowing well that the real test of our product lies not simply in QC data, but in the day-to-day lab bench or production line where failures mean lost time and money.
Direct manufacture sets our Ethanolamine Arachidonic Acid apart from bulk reprocessors, resellers, or brokers who handle third-party materials. Our investment in raw material traceability, hands-on batch oversight, and user-focused adaptations leads to a product well suited for both advanced research and commercial formulation. We don't cut corners to boost yield. Instead, we invest in continuous laboratory validation and cross-checking each batch with end-user protocols.
We know from experience that each lot of AEA must be readily traceable, freshly packed, and transparently characterized. This ensures that whether used in receptor binding, cellular testing, product development, or stability studies, the compound performs as required — every time. We remain committed to this standard because we see the downstream benefits in academic publications, prototype validations, and successful transfer to scale-up production.
Day in and day out, our team faces chemist’s challenges, regulatory scrutiny, shipping unpredictability, and the practical needs of research staff and formulators. This experience shapes every gram of Ethanolamine Arachidonic Acid we manufacture and deliver. By keeping direct control, maintaining rigorous transparency, and staying responsive to feedback, we help ensure that our AEA not only meets, but raises the bar in an increasingly demanding scientific landscape.